Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer.

[1]  The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer , 2012, Journal of Translational Medicine.

[2]  K. Hasegawa,et al.  Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers , 2011, Archives of Gynecology and Obstetrics.

[3]  Yanhong Zhang,et al.  Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions* , 2011, The Journal of Biological Chemistry.

[4]  Elizabeth L. Johnson,et al.  Quiescent Fibroblasts Exhibit High Metabolic Activity , 2010, PLoS biology.

[5]  J. Jónasson,et al.  Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture , 2010, BMC Research Notes.

[6]  Jyrki Lötjönen,et al.  A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses , 2010, PloS one.

[7]  M. Kuroki,et al.  Three-dimensionally specific inhibition of DNA repair-related genes by activated KRAS in colon crypt model. , 2010, Neoplasia.

[8]  M. Carayannopoulos,et al.  Akt2 Modulates Glucose Availability and Downstream Apoptotic Pathways during Development* , 2010, The Journal of Biological Chemistry.

[9]  Wensheng Yan,et al.  Characterization of Functional Domains Necessary for Mutant p53 Gain of Function*♦ , 2010, The Journal of Biological Chemistry.

[10]  Bahram Parvin,et al.  Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D Culture , 2010, PLoS Comput. Biol..

[11]  M. Bissell,et al.  Gene Expression in the Third Dimension: The ECM-nucleus Connection , 2010, Journal of Mammary Gland Biology and Neoplasia.

[12]  R. Kramer,et al.  Differential Epidermal Growth Factor Receptor Signaling Regulates Anchorage-Independent Growth by Modulation of the PI3K/AKT Pathway , 2009, Oncogene.

[13]  K. Griffith,et al.  Expression of metabolically targeted biomarkers in endometrial carcinoma. , 2010, Gynecologic oncology.

[14]  L. Ellenson,et al.  Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma. , 2009, Gynecologic oncology.

[15]  T. Motyl,et al.  Differences in growth and transcriptomic profile of bovine mammary epithelial monolayer and three-dimensional cell cultures. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[16]  Z. Zehner,et al.  Inhibition of vimentin or β1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo , 2009, Molecular Cancer Therapeutics.

[17]  P. Chow,et al.  2-[18f]-2-deoxy-d-glucose (fdg) uptake in human tumor cells is related to the expression of glut-1 and hexokinase ii , 2008, Acta radiologica.

[18]  L. Shaw,et al.  A key tyrosine (Y1494) in the beta4 integrin regulates multiple signaling pathways important for tumor development and progression. , 2008, Cancer research.

[19]  E. Eisenhauer,et al.  Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Elikplimi K. Asem,et al.  Three-Dimensional Cell Culture to Model Epithelia in the Female Reproductive System , 2007, Reproductive Sciences.

[21]  W. Han,et al.  Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin , 2007, Cell Research.

[22]  A. Mes-Masson,et al.  Reproductive Biology and Endocrinology Characterization of En-1078d, a Poorly Differentiated Human Endometrial Carcinoma Cell Line: a Novel Tool to Study Endometrial Invasion in Vitro , 2022 .

[23]  Sigrid Stroobants,et al.  The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer , 2007 .

[24]  M. Nouri,et al.  Effect of matrigel on function and morphology of human endometrial epithelial cell in vitro. , 2007, Iranian biomedical journal.

[25]  A. Miyajima,et al.  Liver progenitor cells develop cholangiocyte-type epithelial polarity in three-dimensional culture. , 2007, Molecular biology of the cell.

[26]  N. Fusenig,et al.  Critical role for NF‐κB‐induced JunB in VEGF regulation and tumor angiogenesis , 2007 .

[27]  S. Knuutila,et al.  Extracellular matrix-induced changes in expression of cell cycle-related proteins and proteasome components in endometrial adenocarcinoma cells. , 2006, Gynecologic Oncology.

[28]  Adrian L Harris,et al.  Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosis , 2006, Modern Pathology.

[29]  Joe W Gray,et al.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.

[30]  A. Mercurio,et al.  The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo. , 2005, Cancer research.

[31]  R. Deberardinis,et al.  The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation , 2005, Oncogene.

[32]  D. Aoki,et al.  Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan. , 2005, Japanese journal of clinical oncology.

[33]  H. Jabbour,et al.  Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  M. Condic,et al.  Cranial neural crest recycle surface integrins in a substratum-dependent manner to promote rapid motility , 2004, The Journal of cell biology.

[35]  E. Asselin,et al.  AKT involvement in cisplatin chemoresistance of human uterine cancer cells. , 2004, Gynecologic oncology.

[36]  Stuart Maudsley,et al.  Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. , 2004, Molecular endocrinology.

[37]  Jaime Prat,et al.  Prognostic parameters of endometrial carcinoma. , 2004, Human pathology.

[38]  H. An,et al.  Molecular characterization of uterine clear cell carcinoma , 2004, Modern Pathology.

[39]  E. Asselin,et al.  Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κB/IκB pathway , 2004, Molecular Cancer.

[40]  H. Jabbour,et al.  Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. , 2003, Reproduction.

[41]  Tsuyoshi Saito,et al.  Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. , 2003, Carcinogenesis.

[42]  Tsuyoshi Saito,et al.  Three-dimensional coculture of endometrial cancer cells and fibroblasts in human placenta derived collagen sponges and expression matrix metalloproteinases in these cells. , 2003, Gynecologic oncology.

[43]  Hyuck Chan Kwon,et al.  A well-defined in vitro three-dimensional culture of human endometrium and its applicability to endometrial cancer invasion. , 2003, Cancer letters.

[44]  R. Hansen,et al.  Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. , 2002, Journal of the National Cancer Institute.

[45]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[46]  M. Grant,et al.  Benzo(a)pyrene, but not 2,3,7,8-tetrachlorodibenzo-p-dioxin, alters cell adhesion proteins in human uterine RL95-2 cells. , 2002, Biochemical and biophysical research communications.

[47]  A. Burgess,et al.  Laminin-10 Mediates Basal and EGF-Stimulated Motility of Human Colon Carcinoma Cells via α3β1 and α6β4 Integrins , 2001 .

[48]  G. Dunselman,et al.  Adhesion of menstrual endometrium to extracellular matrix: the possible role of integrin α6β1 and laminin interaction , 2000 .

[49]  A. Schindler,et al.  Expression pattern of integrin adhesion molecules in endometriosis and human endometrium. , 1998, Human reproduction update.

[50]  S. Fleming,et al.  Distribution of integrins and the extracellular matrix proteins in the baboon endometrium during the menstrual cycle and early pregnancy. , 1997, Biology of reproduction.

[51]  K. Min,et al.  Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. , 1994, Gynecologic oncology.

[52]  H. Westphal,et al.  Analysis of the p53 gene in human uterine carcinoma cell lines. , 1991, Cancer research.